Treatment of recalcitrant verruca vulgaris with Candida antigen in patient with human immunodeficiency virus.

Abstract

Verruca vulgaris is often difficult to treat in individuals with human immunodeficiency virus (HIV) infection. We present a case of an HIV positive 44-year-old male with a 3-year history of multiple recalcitrant verruca vulgaris involving his hands and face. He did not respond to cryotherapy, urea 40% cream, imiquimod 5% cream, paring, intralesional bleomycin, salicylic acid 6% gel, and electrodesiccation and curettage. The patient achieved complete clearance of all warts within 1 month following treatment of his hands with intralesional Candida antigen. This case reports a complete response of verruca vulgaris to intralesional Candida antigen in an immunocompromised patient.

• Authors: Pamela Summers, Patricia Richards-Altmon, Rebat Halder
• Journal: Journal of drugs in dermatology : JDD (J Drugs Dermatol) Vol. 8 Issue 3 Pg. 268-9 (Mar 2009) ISSN: 1545-9616 [Print] United States
• PMID: 19271374 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antigens, Fungal

Topics

• Adult
• Antigens, Fungal (administration & dosage)
• Candida (immunology)
• HIV Infections (complications)
• Humans
• Injections, Intralesional
• Male
• Skin Diseases (therapy)
• Warts (complications, therapy)